AstraZeneca PLC
11978.00
22-八月-25 08:29:58
15 分钟延时
股票
-74.00
-0.61%
今日范围
11940.00 - 12126.00
ISIN
N/A
来源
Cboe
-
SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally
10 9月 2024 08:30:45 条件 NASDAQ US Markets
-
AstraZeneca :Dato-DXd Fails To Significantly Improve Overall Survival In Phase III Lung Cancer Trial
09 9月 2024 18:50:46 条件 NASDAQ US Markets
-
Chinese Authorities Detain AstraZeneca Employees
05 9月 2024 14:39:29 条件 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
03 9月 2024 00:15:42 条件 NetDania Notify
-
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
30 8月 2024 06:35:45 条件 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
30 8月 2024 03:41:41 条件 NetDania Notify
-
Interesting AZN Put And Call Options For November 15th
23 8月 2024 08:14:24 条件 NASDAQ Stocks
-
AZN: Enhertu Gets US Breakthrough Therapy Designation For HER2 Low/Ultralow Metastatic Breast Cancer
19 8月 2024 00:08:28 条件 NASDAQ US Markets
-
AstraZeneca's Imfinzi Gets US Approval For Resectable Early-stage Lung Cancer
16 8月 2024 00:28:46 条件 NASDAQ US Markets
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 8月 2024 04:38:12 条件 NASDAQ Stocks
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 8月 2024 07:27:01 条件 NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 8月 2024 07:42:17 条件 NASDAQ US Markets
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 7月 2024 00:38:02 条件 NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 7月 2024 00:05:05 条件 NASDAQ US Markets
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
24 7月 2024 23:51:34 条件 NASDAQ US Markets
-
Interesting AZN Put And Call Options For August 23rd
03 7月 2024 10:16:51 条件 NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 7月 2024 00:09:21 条件 NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 6月 2024 07:33:02 条件 NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 6月 2024 00:08:02 条件 NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 6月 2024 00:15:21 条件 NASDAQ US Markets